IMZ Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
1,782
+7
+0.4% +$1.63K 0.14% 27
2026
Q1
$434K Buy
1,775
+34
+2% +$7.92K 0.16% 27
2025
Q4
$360K Buy
1,741
+6
+0.3% +$1.19K 0.13% 31
2025
Q3
$322K Buy
1,735
+14
+0.8% +$2.4K 0.12% 33
2025
Q2
$282K Buy
1,721
+9
+0.5% +$1.38K 0.11% 33
2025
Q1
$284K Buy
+1,712
New +$268K 0.13% 35
2024
Q1
Sell
-1,663
Closed -$260K 31
2023
Q4
$260K Buy
+1,663
New +$255K 0.14% 27

Other funds holding JNJ

IMZ Advisory's JNJ Position: Q2 2026 in Review

IMZ Advisory increased its Johnson & Johnson (JNJ) stake by 0.39% in Q2 2026, buying an estimated $1.63K and bringing the position to 1,782 shares worth $452K. The position accounts for 0.14% of the portfolio, ranked #27.

IMZ Advisory first reported a position in JNJ in Q4 2023 and has held it in 7 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • IMZ Advisory held 1,782 shares of Johnson & Johnson worth $452K as of Q2 2026.
  • IMZ Advisory bought 7 Johnson & Johnson shares in Q2 2026, an estimated $1.63K.
  • Johnson & Johnson made up 0.14% of IMZ Advisory's portfolio in Q2 2026, its #27 holding.
  • IMZ Advisory first reported a position in Johnson & Johnson in Q4 2023 and has held it in 7 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on IMZ Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.